News for Astex Pharmaceuticals, Inc. - Google Finance

Astex Pharmaceuticals Announces Presentation of Updated Results of SGI-110 ...

Tue, 18 Jun 2013 18:30:54 GMT

Astex Pharmaceuticals Announces Presentation of Updated Results of SGI-110 ...
PharmaLive (press release) (subscription) - 18 hours ago

DUBLIN, Calif., June 14, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that updated clinical results ...

Data on Astex Candidate - Analyst Blog - NASDAQ

Is Astex Pharmaceuticals, Inc. (ASTX) Going to Burn These Hedge Funds?

Wed, 12 Jun 2013 20:57:00 GMT

Is Astex Pharmaceuticals, Inc. (ASTX) Going to Burn These Hedge Funds?
Insider Monkey (blog) - Jun 12, 2013

Astex Pharmaceuticals, Inc. (NASDAQ:ASTX) was in 16 hedge funds' portfolio at the end of March. ASTX investors should be aware of an increase in hedge fund interest in recent months.

VIVUS Inc. (NASDAQ:VVUS) and Astex Pharmaceuticals, Inc. (NASDAQ:ASTX ... - SBWire (press release)

ASTEX PHARMACEUTICALS INC : Astex Pharmaceuticals to Present at ...

Wed, 29 May 2013 11:17:05 GMT

ASTEX PHARMACEUTICALS INC : Astex Pharmaceuticals to Present at ...
4-traders (press release) - May 29, 2013

DUBLIN, Calif., May 29, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that James S.J.

Losers to Watch: Infinity Pharmaceuticals Inc, Astex Pharmaceuticals, Arris ...

Thu, 23 May 2013 13:41:05 GMT

Losers to Watch: Infinity Pharmaceuticals Inc, Astex Pharmaceuticals, Arris ...
SBWire (press release) - May 23, 2013

Infinity Pharmaceuticals Inc. (NASDAQ:INFI) shares fell 8% to $23.12. The company, on May 15, announced that Phase 1 clinical data for IPI-145, its potent, oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, will be presented at ...

Astex Pharmaceuticals, Inc. Presents at UBS Global Healthcare Conference ...

Mon, 20 May 2013 21:52:23 GMT

Astex Pharmaceuticals, Inc. Presents at UBS Global Healthcare Conference ...
Seeking Alpha - May 20, 2013

Astex Pharmaceuticals, Inc. (ASTX) UBS Global Healthcare Conference May 20, 2013 3:30 PM ET. Unknown Analyst. Good afternoon, everyone, and thank you so much for coming to the 2013 UBS Global Healthcare Conference.

Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) down by 4.30%, Astex ...

Thu, 23 May 2013 04:20:55 GMT

Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) down by 4.30%, Astex ...
NIS - May 23, 2013

Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) closed its day at $12.91 after falling 4.30%, hit a high of $13.65 and a low of $12.65, the average true range of the stock is $0.67.

Invivo Therapeutics Holdings Corp (OTCBB:NVIV) shares are whopping down ...

Thu, 13 Jun 2013 12:11:53 GMT

Invivo Therapeutics Holdings Corp (OTCBB:NVIV) shares are whopping down ...
NIS - Jun 13, 2013

New York, NY - (NISMAGAZINE) - 06/13/2013- Invivo Therapeutics Holdings Corp (OTCBB:NVIV) closed in previous session at $4.17 after going down by $0.09 (-2.11%) during the day.

Astex Pharma To Present At UBS Global Conference ; Webcast At 3:30 PM ET

Mon, 20 May 2013 18:43:10 GMT

Astex Pharma To Present At UBS Global Conference ; Webcast At 3:30 PM ET
NASDAQ - May 20, 2013

(RTTNews.com) - Astex Pharmaceuticals, Inc.( ASTX ) will present at the UBS Global Healthcare Conference in New York City.

Top Seven Percentage Gainers of the US Stock Market: Yingli Green, Qihoo 360 ...

Tue, 18 Jun 2013 12:37:09 GMT

Top Seven Percentage Gainers of the US Stock Market: Yingli Green, Qihoo 360 ...
Equity Observer - Jun 18, 2013

Astex Pharmaceuticals, Inc (NASDAQ:ASTX), on Monday, declared that updated clinical results of its novel hypomethylating agent, SGI-110, were shown in a poster session at the 18th Congress of the European Hematology Association, being held June ...

Hedge Funds Are Buying Endocyte, Inc. (ECYT)

Mon, 17 Jun 2013 12:50:30 GMT

Hedge Funds Are Buying Endocyte, Inc. (ECYT)
Insider Monkey (blog) - Jun 17, 2013

These stocks are Intercept Pharmaceuticals Inc (NASDAQ:ICPT), Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), Keryx Biopharmaceuticals (NASDAQ:KERX), Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), and Kythera Biopharmaceuticals Inc (NASDAQ:KYTH).